Susquehanna International Group, LLP Merrimack Pharmaceuticals Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$13.06 - $15.0 $912,894 - $1.05 Million	-69,900 Reduced 84.52%	12,800 $189,000
Q4 2023 Feb 14, 2024	BUY	$12.02 - $13.41 $370,216 - $413,028	30,800 Added 59.34%	82,700 $1.11 Million
Q3 2023 Nov 14, 2023	BUY	$11.6 - $12.52 $76,560 - $82,632	6,600 Added 14.57%	51,900 $639,000
Q2 2023 Aug 11, 2023	BUY	$12.02 - $13.07 $330,550 - $359,425	27,500 Added 154.49%	45,300 $557,000
Q1 2023 May 16, 2023	SELL	$11.35 - $12.32 $216,785 - $235,312	-19,100 Reduced 51.76%	17,800 $218,000
Q4 2022 Feb 14, 2023	BUY	$3.68 - $12.51 $60,720 - $206,415	16,500 Added 80.88%	36,900 $422,000
Q3 2022 Nov 14, 2022	BUY	$3.7 - $6.06 $75,480 - $123,623	20,400 New	20,400 $77,000
Q1 2022 May 16, 2022	SELL	$3.75 - $6.82 $52,875 - $96,162	-14,100 Reduced 46.08%	16,500 $104,000
Q4 2021 Feb 14, 2022	SELL	$3.75 - $5.1 $27,375 - $37,230	-7,300 Reduced 19.26%	30,600 $120,000
Q3 2021 Nov 15, 2021	BUY	$4.3 - $6.39 $67,080 - $99,684	15,600 Added 69.96%	37,900 $183,000
Q1 2021 May 17, 2021	SELL	$6.15 - $8.7 $1.67 Million - $2.36 Million	-271,500 Reduced 92.41%	22,300 $140,000
Q4 2020 Feb 16, 2021	BUY	$3.69 - $8.31 $991,872 - $2.23 Million	268,800 Added 1075.2%	293,800 $2.02 Million
Q3 2020 Nov 16, 2020	SELL	$3.1 - $4.3 $25,420 - $35,260	-8,200 Reduced 24.7%	25,000 $100,000
Q4 2019 Feb 14, 2020	SELL	$3.15 - $4.67 $21,105 - $31,289	-6,700 Reduced 16.79%	33,200 $105,000
Q3 2019 Nov 14, 2019	BUY	$4.16 - $6.05 $70,304 - $102,245	16,900 Added 73.48%	39,900 $179,000
Q2 2019 Aug 14, 2019	BUY	$4.39 - $5.66 $31,607 - $40,752	7,200 Added 45.57%	23,000 $139,000
Q1 2019 May 15, 2019	BUY	$3.19 - $5.73 $50,402 - $90,534	15,800 New	15,800 $110,000
Q4 2018 Feb 14, 2019	SELL	$2.95 - $4.15 $94,400 - $132,800	-32,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.91 - $4.66 $105,570 - $125,820	-27,000 Reduced 45.76%	32,000 $171,000
Q2 2018 Aug 14, 2018	BUY	$3.86 - $7.61 $18,528 - $36,528	4,800 Added 8.86%	59,000 $290,000
Q1 2018 May 15, 2018	BUY	$6.24 - $9.15 $234,624 - $344,040	37,600 Added 226.51%	54,200 $436,000
Q4 2017 Feb 14, 2018	SELL	$7.99 - $11.87 $157,403 - $233,838	-19,700 Reduced 54.27%	16,600 $170,000
Q3 2017 Nov 14, 2017	BUY	$9.13 - $11.72 $331,419 - $425,436	36,300	36,300 $528,000

Others Institutions Holding MACK

# of Institutions

Shares Held

349

Call Options Held

Put Options Held

View Full List

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account